GSK CONSUMER HEALTHCARE
Ahead of Market: 10 things that will decide D-Street action on Friday
Nifty ended Thursday with a decline of 216 points, driven by strong selling pressure across most sectors. The 50-stock index fell for the fifth consecutive session and is now trading below the crucial 21-day Exponential Moving Average (21EMA).
GSK raises $1.5 billion from sale of remaining Haleon stake
British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.
GSK intends to sell its remaining stake in Haleon
GSK, which initially retained a near 13% stake in Haleon, had over the course of a year lowered its stake to 4.2%. Last year, GSK had said that the Haleon spin-off and subsequent stake sales would allow the company to sharpen its focus on vaccines and infectious diseases and fund deals to bolster a lacklustre drug pipeline.
MNC pharma body OPPI appoints Anil Matai as new director general
The Organisation of Pharmaceutical Producers of India (OPPI) has appointed Anil Matai as its director general. Matai has extensive experience in the pharmaceutical industry, having worked with companies such as Novartis India, GSK India, and Global Pharma. He has also served on the boards of several healthcare companies.
Self-care products set to grow big; no downtrading in healthcare, says Haleon CEO
According to Brian McNamara, the global CEO of consumer healthcare company Haleon, the focus on preventive healthcare post-pandemic is creating growth opportunities for businesses. Consumers are not compromising on health, and there is a growing interest in proactively managing health. Governments worldwide are also promoting self-care to alleviate pressure on healthcare systems.
ET 40 Under Forty: India’s brightest young business leaders
This year, as we continue the journey towards a decade, Startup India remains firmly in focus, in keeping with the country’s standing as the world’s third largest startup ecosystem, and aspiring to be Number 1. Sixteen of the top 40 this year are entrepreneurs – the same as last year – which, at 40%, marked the highest representation of entrepreneurs in ET 40 under Forty’s history.
- Go To Page 1
Kotak initiates coverage on Mankind Pharma, sees 11% upside. 3 reasons why
Kotak Institutional Equities has initiated coverage on Mankind Pharma and given it an 'Add' rating with a target price of Rs 1,875. The brokerage expects Mankind to show significant growth in branded Rx, consumer healthcare and international segments over FY 2023-26E, leading to 15%, 22% and 26% sales, adjusted EBITDA and adjusted PAT CAGRs respectively. The stock is valued at a premium against peers such as Cipla, Zydus, Lupin, Alkem and Dr Reddy's due to its superior growth prospects. The brokerage notes Mankind's consistent outperformance, well-rounded portfolio and industry-leading return ratios.
Focus on consumer goods and healthcare sectors now, says Mahantesh Sabarad
"However, the credit expansion may come with the problem of compressed NIMS. Consumer durables are the sector to avoid due to inflation worries and interest rate hikes, which may affect peak season demand around the summertime".
Hindustan Unilever-GSK Consumer to terminate distribution agreement for OTC products by next year
"The company, GlaxoSmithKline Consumer and GlaxoSmithKline Asia have mutually agreed and expressed their intention to terminate the agreements with effect from 8th November, 2023 and the one year notice period of termination shall commence from 9th November, 2022. This shall not have any material effect on the operations of the company," HUL said in a stock exchange notice.
Ahead of Market: 10 things that will decide stock action on Friday
“The consolidation with high volatility is likely to continue for the next 1-2 sessions. Immediate support is placed at 17,200 and the strong resistance to be watched at 17,500 levels. A decisive move above the hurdle could pull Nifty towards the next upside trajectory of 17,800 levels.”
GSK Consumer Healthcare sets up 27,000 sq. ft. office, embraces smart working
The office has been designed incorporating learnings from the company's recent work-from-home experience.
GSK Pharma sheds 2% as Q3 profit drops, expenses rise
Total income in October-December 2021 stood at Rs 826.24 crore as compared with Rs 805.89 crore in the year-ago period, PTI reported.
Unilever's strategy in spotlight after dropping $68 billion GSK battle
Shares in Unilever, the maker of a range of brands such as Dove soap and Hellmann's mayonnaise, gained 2% after the company said late on Wednesday that it would not raise its rejected 50 billion pound offer.
Healthcare, tech stocks pressure European shares; miners outperform
The pan-European STOXX 600 skid 0.3% after positive trading updates and commodity prices helped spark a rebound in shares in its previous session.
Unilever will not raise rejected 50 bn pound bid for GSK consumer arm
GSK has rejected three bids from Unilever for its consumer arm, which is home to brands such as Sensodyne toothpaste, Emergen-C vitamin supplement and Panadol painkiller, saying the bids "fundamentally undervalued" the business and its prospects.
Unilever still eyes GSK-Pfizer unit after £50 bn bid rebuffed
GSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as the company said the unit was undervalued.
Unilever eyes GSK's consumer goods arm in possible 50 billion-pound deal
Earlier, Britain's Sunday Times said the Unilever bid for the business made late last year was worth roughly 50 billion pounds, and had been rejected as too low by GSK and Pfizer, which owns a minority stake in the division.
Phoenix Mills appoints Anuraag Srivastava as Chief Financial Officer
Srivastava, a chartered accountant, has over 25 years of financial management experience across varied sectors including fast moving consumer goods (FMCG), retail, telecom and infrastructure across multiple geographies. His expertise includes business planning, finance management, and raising private and public capital, Phoenix Mills said in a regulatory filing while announcing the new CFO’s appointment.
GSK to boost spending power of pharma business post break-up
GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day. GSK's share price has fallen 14% over the past 12 months versus a 5% rise in the STOXX Europe 600 Health Care index, hit by a lack of fast-growing products and as patients deferred treatments due to the coronavirus pandemic.
GSK Consumer Healthcare to introduce recyclable toothpaste tubes across its oral health brands
The world's leading consumer healthcare business is partnering with two global packaging suppliers Albea and EPL Global to launch fully recyclable toothpaste tubes, said a statement.
Street bets on GCPL’s rise under new CEO
Even as most of the FMCG companies outperformed the bourses in recent years, GCPL has been an under-performer. For instance, while stocks of most frontline FMCG companies are trading at or near their record highs, the GCPL stock was trading nearly 30 per cent below its record high hit in 2018 before the new CEO announcement.
Unilever may write back ₹59mn provision without ‘goodwill’
Hindustan Unilever announced the acquisition of GSK Consumer Healthcare in an all-stock deal two years ago, valuing the Indian business of GSK at ₹31,700 crore.
HUL appoints Ritesh Tiwari as Chief Financial Officer
"Tiwari will succeed Srinivas Phatak who will move as EVP Financial Control and Risk Management, based out of Unilever's headquarters in London and be part of the Finance Leadership Executive Team," HUL said in a statement.
GSK Consumer forays into nasal wash segment
"Otrivin continues to be the leading nasal decongestant in India as well as globally. As the air quality degrades with each passing day, cleansing the nasal cavity by washing away the excess mucus or the allergen particles such as dust or pollen is an immediate need," GSK Consumer Healthcare OTC & Expert Marketing ISC Area Marketing Lead Vijay Sharma said.
GSK launches global oral care brand Polident in India
Dental experts and chemists will play a critical role in establishing the category in India, GSK said in the statement. “The company will work with experts, who will develop India’s first denture care guidelines. These will put in place a go-to-guide for use of the specialised products in the country,” the statement said.
GSK boost may not be enough to offset HUL’s lockdown hit
Despite the subdued performance, the company is likely to maintain its operating profit margin at about 24%, thanks to savings on advertising spend over the year-ago level and rationalisation of product mix.
GSK preparing to start Rs 28,000 crore stake sale in HUL
ET Now, quoting agencies, said GSK PLc is likely to start the discussion of its stake in the next few days.
Why GCPL, Marico, Britannia & Emami missed the FMCG rally
A significant part of these companies’ portfolios has been hit by poor demand.
Load More
